Zoledronic Acid Versus Alendronate for the Prevention of Bone Loss after Heart or Liver Transplantation

CONTEXT: The first year after transplantation is characterized by rapid bone loss. OBJECTIVE: The aim of this study was to compare zoledronic acid (zoledronate) and alendronate for prevention of transplantation bone loss. DESIGN AND SETTING: A randomized clinical trial was conducted at a transplanta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shane, Elizabeth, Cohen, Adi, Stein, Emily M., McMahon, Donald J., Zhang, Chiyuan, Young, Polly, Pandit, Kavita, Staron, Ronald B., Verna, Elizabeth C., Brown, Robert, Restaino, Susan, Mancini, Donna
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2012
Matèries:
Endocrine Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3591679/
https://ncbi.nlm.nih.gov/pubmed/23024190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-2804
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars